Attached files
| file | filename |
|---|---|
| EX-32 - EX-32 - ARMO BioSciences, Inc. | d557308dex321.htm |
| EX-31.2 - EX-31.2 - ARMO BioSciences, Inc. | d557308dex312.htm |
| EX-31.1 - EX-31.1 - ARMO BioSciences, Inc. | d557308dex311.htm |
| EX-10.6 - EX-10.6 - ARMO BioSciences, Inc. | d557308dex106.htm |
| EX-3.2 - EX-3.2 - ARMO BioSciences, Inc. | d557308dex32.htm |
| EX-3.1 - EX-3.1 - ARMO BioSciences, Inc. | d557308dex31.htm |
| 10-K - FORM 10-K - ARMO BioSciences, Inc. | d557308d10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-222790) pertaining to the ARMO BioSciences, Inc. 2018 Equity Incentive Plan, the ARMO BioSciences, Inc. 2018 Employee Stock Purchase Plan and the ARMO BioSciences, Inc. 2012 Stock Incentive Plan of ARMO BioSciences, Inc. of our report dated March 30, 2018, with respect to the consolidated financial statements of ARMO BioSciences, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2017.
| /s/ Ernst & Young LLP |
| Redwood City, California |
| March 30, 2018 |